EG668210 inhibitors represent a class of small molecules designed to selectively inhibit a specific protein or enzymatic target within biological pathways. These inhibitors typically act by binding to active or allosteric sites on the target protein, modulating its activity. This mechanism of action can result in the downregulation or complete suppression of the target protein's functional role, thus influencing the overall signaling pathways in which the protein is involved. EG668210 inhibitors are structurally diverse, with variations in their core scaffolds, side chains, and substituents. This structural diversity is purposeful, allowing for optimization of binding affinity, specificity, and biochemical stability. The inhibitors often contain functional groups that facilitate strong interactions with the target protein's binding pocket, including hydrogen bonds, hydrophobic interactions, and van der Waals forces. These molecular interactions are crucial for enhancing the potency of the inhibitors while minimizing off-target effects on other proteins.
The design of EG668210 inhibitors also emphasizes their physicochemical properties, such as solubility, permeability, and metabolic stability. These attributes are optimized through structure-activity relationship (SAR) studies, which examine how specific modifications to the inhibitor's chemical structure impact its binding affinity and functional efficacy. As a result, many EG668210 inhibitors exhibit favorable characteristics for bioavailability, allowing them to effectively reach their intended biological target in a variety of environments. Furthermore, these inhibitors are often developed with an eye toward achieving high selectivity for their target protein, reducing potential unwanted interactions that could lead to side effects or interference with other biochemical processes. The highly tailored design of EG668210 inhibitors makes them an important class of molecules for studying cellular signaling and protein function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 is a specific inhibitor of V-ATPase, which can prevent acidification of intracellular organelles and disrupt protein sorting. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
Concanamycin A is another specific inhibitor of V-ATPase, similar in action to Bafilomycin A1, and can inhibit organelle acidification. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Omeprazole is a proton pump inhibitor that can indirectly affect V-ATPase by altering cellular proton gradients and pH. | ||||||
Lansoprazole | 103577-45-3 | sc-203101 sc-203101A | 500 mg 1 g | $59.00 $176.00 | 6 | |
Lansoprazole, similar to Omeprazole, is a proton pump inhibitor that can indirectly affect V-ATPase function. | ||||||
Pantoprazole | 102625-70-7 | sc-204830 sc-204830A | 100 mg 500 mg | $89.00 $255.00 | 2 | |
Pantoprazole is another proton pump inhibitor that can lead to altered proton gradients affecting V-ATPase activity. | ||||||
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $57.00 | 6 | |
Amiloride is a diuretic that inhibits Na+/H+ exchangers, which can affect proton gradients and V-ATPase activity indirectly. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $92.00 $256.00 | 5 | |
Zoledronic Acid can inhibit farnesyl pyrophosphate synthase, potentially affecting protein prenylation and membrane association of V-ATPase. | ||||||
Alendronate acid | 66376-36-1 | sc-337520 | 5 g | $135.00 | 2 | |
Alendronate is a bisphosphonate that can affect osteoclast function by disrupting the V-ATPase, which is essential for their resorptive activity. | ||||||
Rabeprazole | 117976-89-3 | sc-204872 sc-204872A | 10 mg 25 mg | $349.00 $620.00 | 2 | |
Rabeprazole is a proton pump inhibitor that can disturb cellular proton gradients and indirectly affect V-ATPase. | ||||||
Domperidone | 57808-66-9 | sc-203032 sc-203032A | 50 mg 250 mg | $61.00 $287.00 | 2 | |
Domperidone is known to inhibit dopamine receptors but can also alter gastric pH, potentially affecting V-ATPase activity indirectly. | ||||||